-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Adient, Raises Price Target to $33

Benzinga·05/07/2026 22:53:36
Listen to the news
UBS analyst Joseph Spak maintains Adient (NYSE:ADNT) with a Buy and raises the price target from $32 to $33.